Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leads
When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…
India is well positioned to attract future investments: Patrik Jonsson, President, Lilly International
India must step up and actively pursue accelerated regulatory review pathways without sacrificing the quality, said Patrik Jonsson,…
Why the weight-loss drugs battle will intensify in 2026, explained in 5 charts
Novo executives project that oral pills could capture more than a third of the total obesity drug market…